4D Molecular Therapeutics Inc (FDMT)
SG&A Expense Growth
7.16%
Quarterly · Period ending:
FDMT SG&A Expense Growth
Latest reported7.16%period ending
Latest reported7.16%period ending
FDMT Quarterly SG&A Growth (QoQ) (0.00% → 7.16%)
Latest values, visible window
High-resolution chart · PNG
FDMT sg&a expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| 7.1618% | |
| -8.4593% | |
| 7.8567% | |
| 2.7517% | |
| -10.9462% | |
| -11.5608% | |
| 15.6193% | |
| 19.3378% | |
| 2.9823% | |
| -2.9326% | |
| 16.385% | |
| 3.6515% | |
| 9.9975% | |
| -5.61% | |
| 5.1148% | |
| -1.3593% | |
| -0.7776% | |
| 12.309% | |
| -10.4922% | |
| 17.7477% | |
| 25.4375% | |
| -18.962% | |
| 85.7686% | |
| 20.2482% | |
| -16.2014% | |
| -38.681% | |
| 95.249% | |
| 24.9795% | |
| 0% | |
| 23.0537% | |
| 0% | |
| 80.5732% | |
| 0% | |
| 0% |